Trials / Completed
CompletedNCT05192421
An mHealth Exercise Intervention for Sedentary Adults
A Remotely Delivered, Web-Based Exercise Intervention for Sedentary Adults: Randomized Controlled Pilot Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- California State University, Long Beach · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This pilot trial examines the feasibility and acceptability of a web-based, social networking exercise intervention in improving physical activity behavior in adults who do not perform regular exercise.
Detailed description
Primary Objective To determine the feasibility and acceptability of an 8-week remotely-delivered exercise intervention by conducting a randomized controlled study comparing 3 levels of behavioral engagement. Secondary Objectives To compare the effectiveness of 3 levels of web-based interaction on physical activity behavior, physiological training dose, motivation and quality of life. Participants are randomly assigned to 1 of 3 groups: Level 1 (attention control): Participants receive health educational materials through email and the web portal. Level 2 (videos): Participants receive health education materials + access to 24 pre-recorded exercise videos. Level 3 (livestream classes): Participant receive health education materials + livestream exercise classes 3 days/week for 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Wellness Education | Receive wellness education through a weekly email and web portal content. |
| BEHAVIORAL | Exercise Videos | Receive pre-recorded exercise videos through a weekly email and web portal content. |
| BEHAVIORAL | Livestream Classes | Receive 3 videoconference group exercise classes per week for 8 weeks. |
Timeline
- Start date
- 2020-07-07
- Primary completion
- 2022-01-31
- Completion
- 2022-06-30
- First posted
- 2022-01-14
- Last updated
- 2023-09-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05192421. Inclusion in this directory is not an endorsement.